MoneyWorks4Me

Aarti Drugs informs about quarterly statement on investor complaints

22 Oct 2016 Evaluate

Aarti Drugs has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1757.85
Dr. Reddys Labs. 1169.45
Cipla 1298.75
Lupin 1966.60
Zydus Lifesciences 1112.00
View more..